CD40-targeted adenoviral gene transfer to dendritic cells through the use of a novel bispecific single-chain Fv antibody enhances cytotoxic T cell activation

Biragyn, 2000, Designer cancer vaccines are still in fashion, Nat. Med., 6, 966, 10.1038/79649 Steinman, 2002, Exploiting dendritic cells to improve vaccine efficacy, J. Clin. Invest., 109, 1519, 10.1172/JCI0215962 Foged, 2002, Targeting vaccines to dendritic cells, Pharm. Res., 19, 229, 10.1023/A:1014474414097 Jonuleit, 2001, Dendritic cells as a tool to induce anergic and regulatory T cells, Trends Immunol., 22, 394, 10.1016/S1471-4906(01)01952-4 Hawiger, 2001, Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo, J. Exp. Med., 194, 769, 10.1084/jem.194.6.769 Geissmann, 2002, Accumulation of immature langerhans cells in human lymph nodes draining chronically inflamed skin, J. Exp. Med., 196, 417, 10.1084/jem.20020018 Schoenberger, 1998, T-cell help for cytotoxic T lymphocytes is mediated by CD40–CD40L interactions, Nature, 393, 480, 10.1038/31002 Bennett, 1998, Help for cytotoxic-T-cell responses is mediated by CD40 signalling, Nature, 393, 478, 10.1038/30996 Mackey, 1998, Dendritic cells require maturation via CD40 to generate protective antitumor immunity, J. Immunol., 161, 2094, 10.4049/jimmunol.161.5.2094 Jenne, 2001, Viral vectors for dendritic cell-based immunotherapy, Trends Immunol., 22, 102, 10.1016/S1471-4906(00)01813-5 Kirk, 2000, Gene-modified dendritic cells for use in tumor vaccines, Hum. Gene Ther., 11, 797, 10.1089/10430340050015419 Arthur, 1997, A comparison of gene transfer methods in human dendritic cells, Cancer Gene Ther., 4, 17 Zhong, 1999, Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells, Eur. J. Immunol., 29, 964, 10.1002/(SICI)1521-4141(199903)29:03<964::AID-IMMU964>3.0.CO;2-P Dietz, 1998, High efficiency adenovirus-mediated gene transfer to human dendritic cells, Blood, 91, 392, 10.1182/blood.V91.2.392 Rea, 2001, Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene- encoded antigen presentation to cytotoxic T cells, J. Immunol., 166, 5236, 10.4049/jimmunol.166.8.5236 Tillman, 1999, Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector, J. Immunol., 162, 6378, 10.4049/jimmunol.162.11.6378 Rea, 1999, Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset, J. Virol., 73, 10245, 10.1128/JVI.73.12.10245-10253.1999 de Gruijl TD, Luykx-de Bakker SA, Tillman Bw, et al. Prolonged maturation and enhanced transduction of dendritic cells migrated from human skin explants after in situ delivery of CD40-targeted adenoviral vectors. J Immunol 2002;169(9):5322–31. Tillman, 2000, Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model, Cancer Res., 60, 5456 Pereboev, 2002, Coxsackievirus–adenovirus receptor genetically fused to anti-human CD40 scFv enhances adenoviral transduction of dendritic cells, Gene Ther., 9, 1189, 10.1038/sj.gt.3301767 Francisco, 1995, Activity of a single-chain immunotoxin that selectively kills lymphoma and other B-lineage cells expressing the CD40 antigen, Cancer Res., 55, 3099 Francisco, 1997, Construction, expression, and characterization of BD1-G28-5 sFv, a single-chain anti-CD40 immunotoxin containing the ribosome-inactivating protein bryodin, J. Biol. Chem., 272, 24165, 10.1074/jbc.272.39.24165 Watkins, 1997, The adenobody approach to viral targeting: specific and enhanced adenoviral gene delivery, Gene Ther., 4, 1004, 10.1038/sj.gt.3300511 Haisma, 2000, Targeting of adenoviral vectors through a bispecific single-chain antibody, Cancer Gene Ther., 7, 901, 10.1038/sj.cgt.7700198 Kontermann, 1997, Enzyme immunoassays using bispecific diabodies, Immunotechnology, 3, 137, 10.1016/S1380-2933(97)00010-9 Nettelbeck, 2001, Targeting of adenovirus to endothelial cells by a bispecific single—chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105), Mol. Ther., 3, 882, 10.1006/mthe.2001.0342 Bontkes, 2002, Expansion of dendritic cell precursors from human CD34(+) progenitor cells isolated from healthy donor blood growth factor combination determines proliferation rate and functional outcome, J. Leukoc. Biol., 72, 321, 10.1189/jlb.72.2.321 Jonuleit, 2000, Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity, Gene Ther., 7, 249, 10.1038/sj.gt.3301077